Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hanspeter Nick

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 9, 2008
Pharmacokinetics, distribution, metabolism, and excretion of deferasirox and its iron complex in ratsGerard J M Bruin, Thomas Faller, Hansjörg Wiegand, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|December 6, 2006
Deferasirox and deferiprone remove cardiac iron in the iron-overloaded gerbilJohn C Wood, Maya Otto-Duessel, Ignacio Gonzalez, et al.
Blood|July 13, 2006
Action of chelators in iron-loaded cardiac cells: Accessibility to intracellular labile iron and functional consequencesHava Glickstein, Rinat Ben El, Gabi Link, et al.
Circulation|July 20, 2005
Cardiac iron determines cardiac T2*, T2, and T1 in the gerbil model of iron cardiomyopathyJohn C Wood, Maya Otto-Duessel, Michelle Aguilar, et al.
Advances in Experimental Medicine and Biology|February 8, 2003
ICL670A: preclinical profileHanspeter Nick, Agnes Wong, Pierre Acklin, et al.
Bioorganic & Medicinal Chemistry Letters|April 28, 2004
Discovery and SAR of potent, orally available and brain-penetrable 5,6-dihydro-4H-3-thia-1-aza-benzo[e]azulen- and 4,5-dihydro-6-oxa-3-thia-1-aza-benzo[e]azulen derivatives as neuropeptide Y Y5 receptor antagonistsHeinrich Rueeger, Marc Gerspacher, Peter Buehlmayer, et al.
Journal of Biomolecular Screening|November 15, 2012
Identification of cardiac glycoside molecules as inhibitors of c-Myc IRES-mediated translationMarie-Cecile Didiot, Jeffrey Hewett, Thibault Varin, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 9, 2008
Pharmacokinetics, distribution, metabolism, and excretion of deferasirox and its iron complex in ratsGerard J M Bruin, Thomas Faller, Hansjörg Wiegand, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|December 6, 2006
Deferasirox and deferiprone remove cardiac iron in the iron-overloaded gerbilJohn C Wood, Maya Otto-Duessel, Ignacio Gonzalez, et al.
Blood|July 13, 2006
Action of chelators in iron-loaded cardiac cells: Accessibility to intracellular labile iron and functional consequencesHava Glickstein, Rinat Ben El, Gabi Link, et al.
Circulation|July 20, 2005
Cardiac iron determines cardiac T2*, T2, and T1 in the gerbil model of iron cardiomyopathyJohn C Wood, Maya Otto-Duessel, Michelle Aguilar, et al.
Advances in Experimental Medicine and Biology|February 8, 2003
ICL670A: preclinical profileHanspeter Nick, Agnes Wong, Pierre Acklin, et al.
Bioorganic & Medicinal Chemistry Letters|April 28, 2004
Discovery and SAR of potent, orally available and brain-penetrable 5,6-dihydro-4H-3-thia-1-aza-benzo[e]azulen- and 4,5-dihydro-6-oxa-3-thia-1-aza-benzo[e]azulen derivatives as neuropeptide Y Y5 receptor antagonistsHeinrich Rueeger, Marc Gerspacher, Peter Buehlmayer, et al.
Journal of Biomolecular Screening|November 15, 2012
Identification of cardiac glycoside molecules as inhibitors of c-Myc IRES-mediated translationMarie-Cecile Didiot, Jeffrey Hewett, Thibault Varin, et al.
Pageof 2